stella
beta
The Real-world Study of AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING) — Stella
Home
/
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
/
View on ClinicalTrials.gov
Recruiting
Back to Resectable Hepatocellular Carcinoma With High Risk of Recurrence trials
Trial locations
(1 site)
China
The first affiliated hospital of SYSU, Guangzhou, Guangdong